Lin Jiang

572 total citations
42 papers, 370 citations indexed

About

Lin Jiang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lin Jiang has authored 42 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 23 papers in Surgery and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lin Jiang's work include Acute Myocardial Infarction Research (23 papers), Antiplatelet Therapy and Cardiovascular Diseases (19 papers) and Coronary Interventions and Diagnostics (16 papers). Lin Jiang is often cited by papers focused on Acute Myocardial Infarction Research (23 papers), Antiplatelet Therapy and Cardiovascular Diseases (19 papers) and Coronary Interventions and Diagnostics (16 papers). Lin Jiang collaborates with scholars based in China, United States and Hong Kong. Lin Jiang's co-authors include Xiaofang Tang, Jinqing Yuan, Bo Xu, Jue Chen, Yuejin Yang, Xueyan Zhao, Shubin Qiao, Ying Song, Zhan Gao and André Herchuelz and has published in prestigious journals such as Journal of Medicinal Chemistry, The American Journal of Cardiology and Heart.

In The Last Decade

Lin Jiang

39 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Jiang China 12 198 123 70 45 42 42 370
Sida Jia China 11 202 1.0× 141 1.1× 46 0.7× 56 1.2× 40 1.0× 35 372
Bülent Behlül Altunkeser Türkiye 13 255 1.3× 85 0.7× 80 1.1× 30 0.7× 34 0.8× 43 374
Kang‐Yin Chen China 9 202 1.0× 83 0.7× 32 0.5× 42 0.9× 85 2.0× 52 392
Natália António Portugal 11 374 1.9× 100 0.8× 48 0.7× 36 0.8× 111 2.6× 82 557
Florian A. Wenzl Switzerland 12 183 0.9× 119 1.0× 44 0.6× 44 1.0× 66 1.6× 38 394
Elke Arts Netherlands 11 194 1.0× 144 1.2× 35 0.5× 44 1.0× 54 1.3× 17 682
Ingibjörg Jóna Guðmundsdóttir Iceland 15 105 0.5× 241 2.0× 56 0.8× 24 0.5× 72 1.7× 31 526
Clay Cauthen United States 7 216 1.1× 91 0.7× 21 0.3× 73 1.6× 82 2.0× 15 459
Ryo Kameda Japan 13 172 0.9× 197 1.6× 55 0.8× 47 1.0× 59 1.4× 41 424
Claudio Laudani Italy 11 278 1.4× 170 1.4× 69 1.0× 33 0.7× 19 0.5× 40 420

Countries citing papers authored by Lin Jiang

Since Specialization
Citations

This map shows the geographic impact of Lin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Jiang more than expected).

Fields of papers citing papers by Lin Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Jiang. The network helps show where Lin Jiang may publish in the future.

Co-authorship network of co-authors of Lin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Jiang. A scholar is included among the top collaborators of Lin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Jiang. Lin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jun, Zhang, et al.. (2025). Nanoparticle-mediated sodium butyrate delivery for repairing hypoxic-ischemic brain injury in premature infants. Materials Today Bio. 32. 101665–101665. 2 indexed citations
2.
Yuan, Deshan, Yi Yao, Lin Jiang, et al.. (2023). Prognostic impact of lipoprotein(a) in patients undergoing percutaneous coronary intervention modified by low density lipoprotein cholesterol. Clinica Chimica Acta. 540. 117217–117217. 3 indexed citations
3.
Lv, Peng, et al.. (2023). Ischemic stroke prediction of patients with carotid atherosclerotic stenosis via multi-modality fused network. Frontiers in Neuroscience. 17. 1118376–1118376. 10 indexed citations
4.
Tang, Xiaofang, Chen He, Pei Zhu, et al.. (2022). Hyperuricemia is Associated With 2- and 5-Year Adverse Outcomes in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Frontiers in Endocrinology. 13. 852247–852247. 4 indexed citations
5.
Zhao, Xueyan, Jiawen Li, Fangchao Liu, et al.. (2021). The PRECISE-DAPT score and 5-year outcomes after percutaneous coronary intervention: a large-scale, real-world study from China. European Heart Journal - Quality of Care and Clinical Outcomes. 8(8). 812–820. 12 indexed citations
6.
Yuan, Deshan, Sida Jia, Pei Zhu, et al.. (2021). 5-Year Clinical Outcomes of Successful Recanalisation for Coronary Chronic Total Occlusions in Patients With or Without Type 2 Diabetes Mellitus. Frontiers in Cardiovascular Medicine. 8. 691641–691641. 2 indexed citations
7.
Zhao, Xueyan, Jianxin Li, Xiaofang Tang, et al.. (2020). D-dimer as a thrombus biomarker for predicting 2-year mortality after percutaneous coronary intervention. Therapeutic Advances in Chronic Disease. 11. 17 indexed citations
8.
Liu, Ru, Lei Song, Lin Jiang, et al.. (2020). Susceptible gene polymorphism in patients with three-vessel coronary artery disease. BMC Cardiovascular Disorders. 20(1). 172–172. 8 indexed citations
9.
Zhao, Xueyan, Jianxin Li, Xiaofang Tang, et al.. (2019). Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention. Clinical and Applied Thrombosis/Hemostasis. 25. 2873252166–2873252166. 5 indexed citations
10.
Jiang, Ping, Zhan Gao, Wei Zhao, et al.. (2019). Relationship between fibrinogen levels and cardiovascular events in patients receiving percutaneous coronary intervention. Chinese Medical Journal. 132(8). 914–921. 9 indexed citations
11.
Jiang, Ping, Zhan Gao, Wei Zhao, et al.. (2019). Prognostic Significance of In-hospital Acquired Thrombocytopenia in Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. The American Journal of the Medical Sciences. 358(1). 19–25. 1 indexed citations
12.
Liu, Yue, Yi Yao, Xiaofang Tang, et al.. (2019). Evaluation of a novel score for predicting 2-year outcomes in patients with acute coronary syndrome after percutaneous coronary intervention. Journal of the Chinese Medical Association. 82(8). 616–622. 1 indexed citations
13.
14.
15.
Zhang, Ce, Lin Jiang, Lianjun Xu, et al.. (2018). Implications of Hyperuricemia in Severe Coronary Artery Disease. The American Journal of Cardiology. 123(4). 558–564. 16 indexed citations
16.
Tang, Xiaofang, Yi Yao, Ying Song, et al.. (2018). Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome. Chinese Medical Journal. 131(12). 1397–1405. 1 indexed citations
17.
Li, Jianxin, Ying Song, Jingjing Xu, et al.. (2017). Plasma big endothelin-1 and stent thrombosis: An observational study in patients undergoing percutaneous coronary intervention in China. Thrombosis Research. 159. 5–12. 10 indexed citations
18.
Jiang, Ping, Ying Song, Jingjing Xu, et al.. (2013). Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention. Cardiology Journal. 26(2). 138–146. 11 indexed citations
19.
Herchuelz, André, et al.. (2012). β‐Cell preservation and regeneration in diabetes by modulation of β‐cell Ca 2+ homeostasis. Diabetes Obesity and Metabolism. 14(s3). 136–142. 22 indexed citations
20.
Teo, Koon, Clara K Chow, Shofiqul Islam, et al.. (2009). Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study. Heart. 95(22). 1857–1864. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sida Jia Breakdown of academic impact, for papers by Bülent Behlül Altunkeser Breakdown of academic impact, for papers by Kang‐Yin Chen Breakdown of academic impact, for papers by Natália António Breakdown of academic impact, for papers by Florian A. Wenzl Breakdown of academic impact, for papers by Elke Arts Breakdown of academic impact, for papers by Ingibjörg Jóna Guðmundsdóttir Breakdown of academic impact, for papers by Clay Cauthen Breakdown of academic impact, for papers by Ryo Kameda Breakdown of academic impact, for papers by Claudio Laudani
Rankless by CCL
2026